XML 45 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Agreements - Amgen (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2018
item
Sep. 30, 2018
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
item
Sep. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
Collaborative Agreements disclosures            
License and milestone fees   $ 672,000 $ 79,000 $ 13,533,000 $ 49,889,000  
Remaining arrangement consideration to be recognized as license revenue   80,592,000   80,592,000   $ 93,752,000
Expense related to excess inventory   47,243,000 $ 31,689,000 $ 130,775,000 $ 99,896,000  
Amgen            
Collaborative Agreements disclosures            
Number of single-target licenses | item       1    
Number of licenses terminated | item 1          
Potential milestone payment       $ 34,000,000    
Remaining arrangement consideration to be recognized as license revenue   $ 84,000   $ 84,000